- Home
- NXL vs POCI Comparison
NXL vs POCI Comparison
Compare NXL & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- POCI
- Stock Information
- Founded
- NXL 2010
- POCI 1982
- Country
- NXL United States
- POCI United States
- Employees
- NXL N/A
- POCI N/A
- Industry
- NXL Medical Specialities
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NXL Health Care
- POCI Health Care
- Exchange
- NXL Nasdaq
- POCI Nasdaq
- Market Cap
- NXL 31.1M
- POCI 31.0M
- IPO Year
- NXL 2022
- POCI N/A
- Fundamental
- Price
- NXL $1.69
- POCI $3.95
- Analyst Decision
- NXL Strong Buy
- POCI
- Analyst Count
- NXL 1
- POCI 0
- Target Price
- NXL $5.00
- POCI N/A
- AVG Volume (30 Days)
- NXL 117.5K
- POCI 11.7K
- Earning Date
- NXL 05-09-2025
- POCI 05-14-2025
- Dividend Yield
- NXL N/A
- POCI N/A
- EPS Growth
- NXL N/A
- POCI N/A
- EPS
- NXL N/A
- POCI N/A
- Revenue
- NXL $168,721.00
- POCI $18,682,766.00
- Revenue This Year
- NXL $79.59
- POCI N/A
- Revenue Next Year
- NXL $334.65
- POCI N/A
- P/E Ratio
- NXL N/A
- POCI N/A
- Revenue Growth
- NXL 52.35
- POCI N/A
- 52 Week Low
- NXL $0.53
- POCI $3.47
- 52 Week High
- NXL $4.49
- POCI $6.90
- Technical
- Relative Strength Index (RSI)
- NXL 37.97
- POCI 40.65
- Support Level
- NXL $1.56
- POCI $3.90
- Resistance Level
- NXL $2.31
- POCI $4.28
- Average True Range (ATR)
- NXL 0.23
- POCI 0.28
- MACD
- NXL 0.01
- POCI -0.00
- Stochastic Oscillator
- NXL 24.27
- POCI 19.57
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.